Docket Room.
SB 837·MD·senate

Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board

FailedFiled Feb 6, 2026
Sponsor: Ready
Latest Action

Hearing (Senate)

Mar 4, 2026

Email me when SB 837 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 837. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill stops managed‑care organizations, insurers, nonprofit health plans and HMOs from using prior authorizations, step‑therapy or fail‑first rules on prescription drugs that the Prescription Drug Affordability Board (PDAB) has reviewed, when the board has not flagged an affordability problem, has issued a policy recommendation, or has set an upper payment limit. It also limits how these entities can limit, restrict, or remove such drugs from their formularies. The changes aim to improve patient access to affordable medicines.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 837

3 free questions a day, no account

Hearings

History

  1. Hearing 3/04 at 1:00 p.m.
  2. First Reading Finance

Sponsors

  • Ready · sponsor
  • Lam

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 837 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 837 free

Or ask your AI assistant about SB 837 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice